Microemulsion formulations comprising particular substance P antagonists

Details for Australian Patent Application No. 2005210134 (hide)

Owner Novartis AG

Inventors Ottinger, Isabel; Ries, Angelika; Luckel, Barbara; Bueb, Waltraud; Reinhart, Thomas

Agent Davies Collison Cave

Pub. Number AU-B-2005210134

PCT Pub. Number WO2005/074891

Priority 0402679.5 06.02.04 GB

Filing date 4 February 2005

Wipo publication date 18 August 2005

Acceptance publication date 22 May 2008

International Classifications

A61K 31/164 (2006.01) - of a carboxylic acid with an aminoalcohol, e.g. ceramides

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

Event Publications

10 August 2006 PCT application entered the National Phase

  PCT publication WO2005/074891 Priority application(s): WO2005/074891

22 May 2008 Application Accepted

  Published as AU-B-2005210134

18 September 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005210136-Casing for a blister package

2005210132-Device for treating using magnetic fields